We are live on ! Find out more
PROF

Profound Medical
PROF

44 hedge funds and large institutions have $84.6M invested in Profound Medical in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,225% more call options, than puts

Call options by funds: $3.78M | Put options by funds: $285K

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1.81% less ownership

Funds ownership: 47.07% → 45.26% (-1.8%)

4% less funds holding

Funds holding: 46 → 44 (-2)

23% less capital invested

Capital invested by funds: $110M → $84.6M (-$25.1M)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
44
Holders Change
-2
Holders Change %
-4.35%
% of All Funds
0.69%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
15
Reduced
13
Closed
6
Calls
$3.78M
Puts
$285K
Net Calls
+$3.49M
Net Calls Change
+$1.88M

Top Buyers

Rank Fund Capital Flow
1
LBA
Letko, Brosseau & Associates
Quebec, Canada
+$4.59M
2
GS
Gagnon Securities
New York
+$2.38M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$578K
4
Fidelity International
Fidelity International
Bermuda
+$385K
5
GA
Gagnon Advisors
New York
+$374K

Top Sellers

Rank Fund Capital Flow
1
BC
Blackcrane Capital
Washington
-$7.19M
2
ACM
Altium Capital Management
New York
-$1.69M
3
TIM
Timelo Investment Management
Ontario, Canada
-$1.13M
4
CM
Caption Management
Oklahoma
-$851K
5
RA
Royce & Associates
New York
-$592K
Name Holding Trade Value Shares
Change 		Change in
Stake
MIM
26
MTM Investment Management
South Carolina
$180K -$2.89K -300 -1%
Jane Street
27
Jane Street
New York
$132K +$142K +14,747 New
HA
28
Harbor Advisors
Florida
$112K – – –
SSA
29
Schonfeld Strategic Advisors
New York
$102K -$5.78K -600 -5%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$97K – – –
Morgan Stanley
31
Morgan Stanley
New York
$72K -$7.22K -750 -9%
CAPTRUST Financial Advisors
32
CAPTRUST Financial Advisors
North Carolina
$54K – – –
SWA
33
SOA Wealth Advisors
New York
$36K – – –
TWC
34
TD Waterhouse Canada
Ontario, Canada
$11K – – –
Optiver Holding
35
Optiver Holding
Netherlands
$11K +$8.54K +887 +261%
Wells Fargo
36
Wells Fargo
California
$9K – – –
Osaic Holdings
37
Osaic Holdings
Arizona
$7K – – –
FDCDDQ
38
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4.69K – – –
Toronto Dominion Bank
39
Toronto Dominion Bank
Ontario, Canada
$4K +$3.86K +401 +4,010%
HIA
40
Harbor Investment Advisory
Maryland
$2K – – –
ACM
41
Aquatic Capital Management
Illinois
$2K +$1.93K +200 New
TRCT
42
Tower Research Capital (TRC)
New York
$1K -$1.22K -127 -48%
Group One Trading
43
Group One Trading
Illinois
$1K – – –
AFM
44
Anson Funds Management
Texas
– -$388K -34,406 Closed
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
– -$323K -33,496 Closed
Citadel Advisors
46
Citadel Advisors
Florida
– -$321K -33,343 Closed
Wolverine Trading
47
Wolverine Trading
Illinois
– -$104K -10,811 Closed
UBS Group
48
UBS Group
Switzerland
– -$16K -1,428 Closed
Bessemer Group
49
Bessemer Group
New Jersey
– -$2K -165 Closed
PA
50
Parallel Advisors
California
– +$289 +30 New
1
2

PROF Hedge Fund Activity: Q1 2022 in Review

44 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q1 2022, worth a combined $84.6M — down 23% from $110M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of PROF and 4 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 15 added.

The largest buyer was Letko, Brosseau & Associates, adding an estimated $4.59M. The largest seller was Blackcrane Capital, cutting an estimated $7.19M.

  • 44 institutional investors held Profound Medical (PROF) as of Q1 2022, down from 46 in Q4 2021.
  • Funds reported $84.6M of Profound Medical stock for Q1 2022, down 23% quarter-over-quarter.
  • 4 funds opened new Profound Medical positions in Q1 2022 and 6 closed out, a net change of -2 holders.
  • The largest Profound Medical buyer in Q1 2022 was Letko, Brosseau & Associates, an estimated $4.59M added.
  • The largest Profound Medical seller in Q1 2022 was Blackcrane Capital, an estimated $7.19M sold.

Based on aggregated 13F filings for Q1 2022.